ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS
Published: 13/10/21, 08:29am (AEST)•8 pages